New York State Component A: BD-STEPS II Core
New York State Component A: BD-STEPS II Core
批准号:
10421039
负责人:
Meredith M Howley
金额:
$80.0万
依托单位国家:
美国
项目类别:
财政年份:
2018
资助国家:
美国
项目状态:
已结题
起止时间:
2018-09-01 至 2023-08-31
中文摘要
点击翻译按钮获取中文摘要
英文摘要
Project Summary
The New York Center for Birth Defects Research and Prevention (NYCBDRP) proposes to
continue its strong record of conducting epidemiologic research to identify the causes of birth
defects through its participation in the Birth Defects Study to Evaluate Pregnancy exposureS II
(BD-STEPS II). BD-STEPS II seeks to build on existing efforts to identify maternal exposures in
early pregnancy that may increase the risk for having a pregnancy affected by certain major,
structural birth defects. The NYCBDRP is well positioned to successfully implement BD-STEPS
II. The NYCBDRP has been a major contributor to CDC's collaborative National Birth Defects
Prevention Study (NBDPS) and the Birth Defects Study To Evaluate Pregnancy exposureS I
(BD-STEPS I) since 1996. NYCBDRP researchers have already used NBDPS/BD-STEPS I data
extensively to study the three main focus areas of BD-STEPS II: acute conditions such as
infections; chronic conditions such as autoimmune disease, hypertension, and asthma; and
medications to treat these conditions. The NYCBDRP has an experienced team in place to
successfully implement all aspects of the proposed study: case and control ascertainment,
clinical and contact information abstraction and review, subject recruitment, newborn
bloodspot collection, linkages to state infectious disease surveillance systems, linkages to the
New York State All Payer Database (APD) to validate self-reported medication use, and
innovative epidemiologic investigations. The NYCBDRP research agenda will focus on
expanding medication analyses using new BD-STEPS questions, developing analytic methods to
identify risk factors for rare defects and patterns of co-occurring birth defects, and exploring the
joint effects of chronic conditions and treatments on birth defect risk. The proposed pilot
validation study will build on NYCBDRP subject matter expertise by focusing on
antihypertensive medication use. Through a close relationship with the University at Albany
School of Public Health, the NYCBDRP will continue to attract and mentor graduate-level
students to conduct master's and dissertation projects using NBDPS/BD-STEPS data. From its
position within the New York State Department of Health (NYSDOH), the NYCBDRP will
leverage considerable NYSDOH resources through donated staff time, privileged access to
individual medical records, the Congenital Malformations Registry, infectious disease
surveillance systems, and the APD, and affiliation with the world-renowned Wadsworth Center
laboratory for genetic studies.
期刊论文(10)
专著(0)
科研奖励(0)
会议论文
登录
查看更多内容
DOI:
10.1002/ajmg.a.62546
发表时间:
2022-02
期刊:
AMERICAN JOURNAL OF MEDICAL GENETICS PART A
影响因子:
2
作者:
[Nalbandyan, Marine, Howley, Meredith M., Cunniff, Christopher M., Leckman-Westin, Emily, Browne, Marilyn L.]
通讯作者:
Browne, Marilyn L.
DOI:
10.1002/bdr2.1616
发表时间:
2020-01-15
期刊:
Birth defects research
影响因子:
2.1
作者:
[Fisher SC, Siag K, Howley MM, Van Zutphen AR, Reefhuis J, Browne ML, National Birth Defects Prevention Study]
通讯作者:
National Birth Defects Prevention Study
DOI:
10.1093/jn/nxy246
发表时间:
2019-02
期刊:
The Journal of nutrition
影响因子:
--
作者:
[Thanh T. Hoang;Y. Lei;L. E. Mitchell;Shreela V. Sharma;M. Swartz;D. Waller;R. Finnell;Renata H. Benjamin;M. Browne;M. Canfield;P. Lupo;Paige McKenzie;G. Shaw;A. Agopian]
通讯作者:
Thanh T. Hoang;Y. Lei;L. E. Mitchell;Shreela V. Sharma;M. Swartz;D. Waller;R. Finnell;Renata H. Benjamin;M. Browne;M. Canfield;P. Lupo;Paige McKenzie;G. Shaw;A. Agopian
Agreement between maternal report and medical records on use of medications during early pregnancy in New York.
纽约孕产妇报告和医疗记录之间关于妊娠早期药物使用的协议。
DOI:
10.1002/bdr2.2151
发表时间:
2023
期刊:
Birth defects research
影响因子:
2.1
作者:
[Howley,MeredithM, Fisher,SarahC, Fuentes,MarguerittaA, Werler,MarthaM, Tracy,Melissa, Browne,MarilynL, BirthDefectsStudyToEvaluatePregnancyExposureS]
通讯作者:
BirthDefectsStudyToEvaluatePregnancyExposureS
DOI:
10.1016/j.ypmed.2022.107272
发表时间:
2022-11
期刊:
PREVENTIVE MEDICINE
影响因子:
5.1
作者:
[Simeone, Regina M., Reefhuis, Jennita, Jamieson, Denise J., Drews-Botsch, Carolyn D., Lash, Timothy L., Fisher, Sarah C., Howley, Meredith M., Evans, Shannon, Howards, Penelope P., Natl Birth Defects Prevention Study]
通讯作者:
Natl Birth Defects Prevention Study
共 8 条
海外基金